SCOPE Summit
Join us at SCOPE Summit, happening February 11-14! Meet TFS’s experienced CRO team, including Mike Mendoza, who will be speaking over RBQM, to learn more about our tailored clinical development and resourcing solutions. We combine the full-service capabilities and global reach of a large CRO with the flexibility and personal approach only a mid-size CRO can deliver.
Why TFS? Experience scientific and medical excellence across diverse therapeutic areas. Our seasoned professionals ensure solution-driven outcomes, allowing sponsors to concentrate on advancing clinical innovations. TFS CRO provides industry-leading capabilities in the following areas:
- Oncology and Hematology
- Dermatology, Immunology, and Inflammatory Disease
- Ophthalmology
- Internal Medicine & Neuroscience
- Strategic Resourcing Solutions
Contact us today to connect during the conference and discover how TFS can be your strategic CRO partner in clinical development. See you at SCOPE Summit!
Attend Our Presentation with Medidata:
February 13, 12:50-1:20 PM
By: Mike Mendoza, TFS
and Olgica Klindworth, Medidata
RBQM: The Connective Tissue for Clinical Data Quality
Ensuring clinical data quality is a cross-functional responsibility that starts well before the first patient is enrolled. Why, then, do we still pigeonhole RBQM as a niche and often only a monitoring exercise? We think one reason is that the current implementation of RBQM in many organizations lacks one source of data truth, real-time access to data, and sophisticated tools to identify signals of risks sooner and make adequate decisions. In this session, we’ll present a different view on how RBQM can be a connective tissue, helping break operational silos and weaving data quality oversight into the DNA of the trial’s lifecycle.